These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2008420)

  • 1. Planning the analysis of a breast cancer prevention trial.
    Moon TE
    Prev Med; 1991 Jan; 20(1):109-18. PubMed ID: 2008420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspects of the science of cancer prevention trials: lessons from the conduct and planning of clinical trials of a low-fat diet intervention among women.
    Prentice RL
    Prev Med; 1991 Jan; 20(1):147-57. PubMed ID: 2008423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of partial noncompliance on the power of a clinical trial.
    Freedman LS
    Control Clin Trials; 1990 Jun; 11(3):157-68. PubMed ID: 2163811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basics of designing a clinical trial: part II.
    Whitney JD
    J Wound Ostomy Continence Nurs; 2000 Nov; 27(6):293-5. PubMed ID: 11096408
    [No Abstract]   [Full Text] [Related]  

  • 5. The Fox guarding the clinical trial: internal vs. external validity in randomized studies.
    Goodwin PJ; Pritchard KI; Spiegel D
    Psychooncology; 1999; 8(3):275. PubMed ID: 10390742
    [No Abstract]   [Full Text] [Related]  

  • 6. Interpretation of cancer prevention trials.
    Moon TE
    Prev Med; 1989 Sep; 18(5):721-31. PubMed ID: 2694166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. n-of-1 randomized controlled trials: an opportunity for complementary and alternative medicine evaluation.
    Johnston BC; Mills E
    J Altern Complement Med; 2004 Dec; 10(6):979-84. PubMed ID: 15673992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some controversies in planning and analysing multi-centre trials.
    Senn S
    Stat Med; 1998 Aug 15-30; 17(15-16):1753-65; discussion 1799-800. PubMed ID: 9749445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design issues for a breast cancer chemoprevention trial.
    DeMets DL; Newcomb PA; Carey P
    Prev Med; 1991 Jan; 20(1):101-8. PubMed ID: 2008419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of preservation of the ethical principle of equipoise in the design of clinical trials: relative impact of the methodological quality domains on the treatment effect in randomized controlled trials.
    Djulbegovic B; Cantor A; Clarke M
    Account Res; 2003; 10(4):301-15. PubMed ID: 14989285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rejoiner to Fox.
    Speca M
    Psychooncology; 1999; 8(3):276. PubMed ID: 10390743
    [No Abstract]   [Full Text] [Related]  

  • 12. Methodologic considerations in the design and conduct of randomized trials: the U.S. Physicians' Health Study.
    Hennekens CH; Buring JE
    Control Clin Trials; 1989 Dec; 10(4 Suppl):142S-150S. PubMed ID: 2605963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methodology of superiority vs. equivalence trials and non-inferiority trials.
    Christensen E
    J Hepatol; 2007 May; 46(5):947-54. PubMed ID: 17412447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. National Surgical Adjuvant Breast and Bowel Project breast cancer prevention trial: a reflective commentary.
    Fisher B
    J Clin Oncol; 1999 May; 17(5):1632-9. PubMed ID: 10334553
    [No Abstract]   [Full Text] [Related]  

  • 15. Basics of designing a clinical trial: part I.
    Whitney JD
    J Wound Ostomy Continence Nurs; 2000 Sep; 27(5):257-9. PubMed ID: 10999963
    [No Abstract]   [Full Text] [Related]  

  • 16. Recruitment strategies for a possible tamoxifen trial.
    Kuller LH
    Prev Med; 1991 Jan; 20(1):119-24. PubMed ID: 1901168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The behavioral dynamics of clinical trials.
    Leventhal H; Nerenz DR; Leventhal EA; Love RR; Bendena LM
    Prev Med; 1991 Jan; 20(1):132-46. PubMed ID: 2008422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer prevention: a summary of the chemoprevention trial with tamoxifen.
    Gould K; Gates ML; Miaskowski C
    Oncol Nurs Forum; 1994 Jun; 21(5):835-40. PubMed ID: 7937245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How much 'better' is good enough? The magnitude of treatment effect in clinical trials.
    Raju TN; Langenberg P; Sen A; Aldana O
    Am J Dis Child; 1992 Apr; 146(4):407-11. PubMed ID: 1558071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current development in clinical trials: issues old and new.
    DeMets DL
    Stat Med; 2012 Nov; 31(25):2944-54. PubMed ID: 22736410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.